Benda Pharmaceutical, Inc. and China Shuangjii Cement Ltd., Order of Suspension of Trading

---
identifier: "/us/fr/2013-11916"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Benda Pharmaceutical, Inc. and China Shuangjii Cement Ltd., Order of Suspension of Trading"
title_number: 0
title_name: "Federal Register"
section_number: "2013-11916"
section_name: "Benda Pharmaceutical, Inc. and China Shuangjii Cement Ltd., Order of Suspension of Trading"
positive_law: false
currency: "2013-05-17"
last_updated: "2013-05-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Securities and Exchange Commission"
document_number: "2013-11916"
document_type: "notice"
publication_date: "2013-05-17"
agencies:
  - "Securities and Exchange Commission"
fr_citation: "78 FR 29200"
fr_volume: 78
docket_ids:
  - "File No. 500-1"
---


#  Benda Pharmaceutical, Inc. and China Shuangjii Cement Ltd., Order of Suspension of Trading

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Benda Pharmaceutical, Inc. because it has not filed any periodic reports since the period ended September 30, 2010.

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of China Shuangji Cement Ltd. because it has not filed any periodic reports since the period ended September 30, 2010.

The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed companies is suspended for the period from 9:30 a.m. EDT on May 15, 2013, through 11:59 p.m. EDT on May 29, 2013.

By the Commission.

Lynn M. Powalski,

Deputy Secretary.